Panagora Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $109M | Buy |
175,291
+70,066
| +67% | +$47.7M | 0.34% | 55 |
|
|
2026
Q1 | $81.3M | Buy |
105,225
+57,540
| +121% | +$44.1M | 0.3% | 81 |
|
|
2025
Q4 | $36.8M | Sell |
47,685
-29,988
| -39% | -$20.4M | 0.13% | 158 |
|
|
2025
Q3 | $43.7M | Buy |
77,673
+75,493
| +3,463% | +$42.7M | 0.18% | 125 |
|
|
2025
Q2 | $1.14M | Sell |
2,180
-100,768
| -98% | -$56.2M | 0.01% | 598 |
|
|
2025
Q1 | $65.3M | Sell |
102,948
-334
| -0.3% | -$230K | 0.33% | 65 |
|
|
2024
Q4 | $73.6M | Sell |
103,282
-48,880
| -32% | -$41M | 0.34% | 70 |
|
|
2024
Q3 | $160M | Sell |
152,162
-18,596
| -11% | -$20.7M | 0.76% | 23 |
|
|
2024
Q2 | $179M | Buy |
170,758
+2,803
| +2% | +$2.72M | 0.9% | 18 |
|
|
2024
Q1 | $162M | Buy |
167,955
+12,997
| +8% | +$12.4M | 0.84% | 17 |
|
|
2023
Q4 | $136M | Sell |
154,958
-3,486
| -2% | -$2.87M | 0.76% | 25 |
|
|
2023
Q3 | $130M | Buy |
158,444
+2,364
| +2% | +$1.86M | 0.81% | 22 |
|
|
2023
Q2 | $112M | Buy |
156,080
+8,677
| +6% | +$6.69M | 0.66% | 23 |
|
|
2023
Q1 | $121M | Buy |
147,403
+16,301
| +12% | +$12.3M | 0.77% | 19 |
|
|
2022
Q4 | $94.6M | Sell |
131,102
-34,854
| -21% | -$25.7M | 0.62% | 31 |
|
|
2022
Q3 | $114M | Sell |
165,956
-2,777
| -2% | -$1.75M | 0.79% | 19 |
|
|
2022
Q2 | $99.7M | Sell |
168,733
-5,670
| -3% | -$3.69M | 0.65% | 22 |
|
|
2022
Q1 | $122M | Buy |
174,403
+1,567
| +0.9% | +$991K | 0.66% | 22 |
|
|
2021
Q4 | $109M | Sell |
172,836
-14,171
| -8% | -$8.71M | 0.58% | 32 |
|
|
2021
Q3 | $113M | Buy |
187,007
+24,981
| +15% | +$15.5M | 0.6% | 28 |
|
|
2021
Q2 | $90.5M | Buy |
162,026
+14,706
| +10% | +$7.45M | 0.48% | 41 |
|
|
2021
Q1 | $69.7M | Buy |
147,320
+11,148
| +8% | +$5.43M | 0.39% | 52 |
|
|
2020
Q4 | $65.8M | Buy |
136,172
+5,787
| +4% | +$3.12M | 0.39% | 55 |
|
|
2020
Q3 | $73M | Sell |
130,385
-2,586
| -2% | -$1.57M | 0.46% | 45 |
|
|
2020
Q2 | $82.9M | Sell |
132,971
-32,527
| -20% | -$18.5M | 0.53% | 33 |
|
|
2020
Q1 | $80.8M | Buy |
165,498
+41,269
| +33% | +$17M | 0.57% | 33 |
|
|
2019
Q4 | $46.6M | Buy |
124,229
+21,802
| +21% | +$7.34M | 0.21% | 115 |
|
|
2019
Q3 | $28.4M | Buy |
102,427
+2,999
| +3% | +$887K | 0.13% | 160 |
|
|
2019
Q2 | $31.1M | Buy |
99,428
+38,672
| +64% | +$12.9M | 0.14% | 162 |
|
|
2019
Q1 | $24.9M | Buy |
60,756
+52,675
| +652% | +$21.7M | 0.11% | 183 |
|
|
2018
Q4 | $3.02M | Sell |
8,081
-97,994
| -92% | -$35.9M | 0.01% | 615 |
|
|
2018
Q3 | $42.9M | Buy |
106,075
+9,481
| +10% | +$3.61M | 0.16% | 147 |
|
|
2018
Q2 | $33.3M | Sell |
96,594
-823
| -0.8% | -$257K | 0.13% | 171 |
|
|
2018
Q1 | $33.5M | Buy |
97,417
+42,662
| +78% | +$14.8M | 0.13% | 164 |
|
|
2017
Q4 | $20.6M | Sell |
54,755
-12,922
| -19% | -$5.23M | 0.08% | 245 |
|
|
2017
Q3 | $30.3M | Sell |
67,677
-3,613
| -5% | -$1.72M | 0.12% | 183 |
|
|
2017
Q2 | $35M | Buy |
71,290
+7,256
| +11% | +$3.18M | 0.14% | 162 |
|
|
2017
Q1 | $24.8M | Sell |
64,034
-1,868
| -3% | -$692K | 0.1% | 216 |
|
|
2016
Q4 | $24.2M | Sell |
65,902
-3,569
| -5% | -$1.36M | 0.11% | 190 |
|
|
2016
Q3 | $27.9M | Buy |
69,471
+11,806
| +20% | +$4.74M | 0.13% | 156 |
|
|
2016
Q2 | $20.1M | Sell |
57,665
-1,294
| -2% | -$498K | 0.1% | 213 |
|
|
2016
Q1 | $21.3M | Sell |
58,959
-18,821
| -24% | -$7.76M | 0.11% | 202 |
|
|
2015
Q4 | $42.2M | Sell |
77,780
-5,367
| -6% | -$2.91M | 0.21% | 116 |
|
|
2015
Q3 | $38.7M | Sell |
83,147
-18,072
| -18% | -$9.71M | 0.2% | 118 |
|
|
2015
Q2 | $51.6M | Sell |
101,219
-732
| -0.7% | -$357K | 0.26% | 90 |
|
|
2015
Q1 | $46M | Buy |
101,951
+41,312
| +68% | +$17.5M | 0.23% | 109 |
|
|
2014
Q4 | $24.9M | Buy |
60,639
+47,094
| +348% | +$18.5M | 0.13% | 190 |
|
|
2014
Q3 | $4.88M | Buy |
13,545
+10,652
| +368% | +$3.57M | 0.02% | 501 |
|
|
2014
Q2 | $817K | Sell |
2,893
-2,112
| -42% | -$626K | ﹤0.01% | 1210 |
|
|
2014
Q1 | $1.5M | Buy |
5,005
+643
| +15% | +$198K | 0.01% | 990 |
|
|
2013
Q4 | $1.2M | Sell |
4,362
-835
| -16% | -$240K | 0.01% | 1098 |
|
|
2013
Q3 | $1.63M | Buy |
5,197
+272
| +6% | +$71.5K | 0.01% | 900 |
|
|
2013
Q2 | $1.11M | Buy |
+4,925
| New | +$1.15M | 0.01% | 1020 |
|
Other funds holding REGN
Panagora Asset Management's REGN Position: Q2 2026 in Review
Panagora Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 67% in Q2 2026, buying an estimated $47.7M and bringing the position to 175,291 shares worth $109M. The position accounts for 0.34% of the portfolio, ranked #55.
Panagora Asset Management first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $179M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Panagora Asset Management held 175,291 shares of Regeneron Pharmaceuticals worth $109M as of Q2 2026.
- Panagora Asset Management bought 70,066 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $47.7M.
- Regeneron Pharmaceuticals made up 0.34% of Panagora Asset Management's portfolio in Q2 2026, its #55 holding.
- Panagora Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Panagora Asset Management's Regeneron Pharmaceuticals position peaked at $179M in Q2 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.